Ashley Marie Bright, | |
712 Mercer St, Princeton, WV 24740-3114 | |
(304) 323-3069 | |
(304) 324-7946 |
Full Name | Ashley Marie Bright |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 712 Mercer St, Princeton, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215648324 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 33102 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ashley Marie Bright, 212 Karens Way, Princeton, WV 24739-4645 Ph: (304) 800-9809 | Ashley Marie Bright, 712 Mercer St, Princeton, WV 24740-3114 Ph: (304) 323-3069 |
News Archive
The shifts, which often happen without warning, come as the state works to verify incomes and make sure consumers are in appropriate health plans, the Associated Press reports.
News outlets report on some of the challenges and sign-up tallies for state-based online insurance marketplaces in California, Minnesota, Washington and Maryland. Also in the news, progress updates regarding outreach efforts and small businesses that are attempting to use the exchanges.
The largest survey to date of the health of trafficking survivors has found high levels of abuse and serious harm associated with human trafficking. For the first time, the findings reveal severe mental and physical health problems experienced by men, women and children trafficked for forced labour and sexual exploitation in Southeast Asia.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
Researchers in the United States, China, and the UK have called for immediate large-scale clinical trials of an antibiotic called rapamycin as a prophylactic and treatment approach to coronavirus disease 2019 (COVID-19) in older individuals.
› Verified 7 days ago